問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberI8F-MC-GPIJ
Active

2022-10-01 - 2027-12-31

Phase III

Not yet recruiting11

  • Trial Applicant

    ELI LILLY AND COMPANY(TAIWAN), INC.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator 呂介華

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Yi-Ching Yang 未分科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 施志遠

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 彭渝森

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 方志元

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 劉銘恩

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Chun-Yao Huang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Shih-Hsien Sung

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Hung-I Yeh 未分科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    160-320 participants

  • Global

    15000 participants